로딩 중…
지수 로딩 중…
GeneDx Holdings Corp.
WGS· NASDAQ· Health Care· Health Care Equipment & Services
$67.86+4.22%
2026-08-03
Financials
Valuation Metrics
GeneDx Holdings Corp.'s Market Cap is $2.01B. At end of 2025 it was $3.50B. Ranked #2051 of 3,112 in US market (top 66%), #786 of 1,445 on NASDAQ (top 54%), #123 of 206 in Health Care Equipment & Services (top 60%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.01B | US#2,051/3,112 Sec#123/206 |
| Revenue | $443M | US#2,407/3,112 Sec#149/206 |
| Net Income | $-78M | US—/3,112 Sec—/206 |
| Total Assets | $506M | US#2,735/3,112 Sec#159/206 |
| Net Assets | $254M | US#2,632/3,112 Sec#159/206 |
| Value | ||
| P/B | 7.93x | US#2,489/3,112 Sec#161/206 |
| P/S | 4.55x | US#2,196/3,112 Sec#154/206 |
| FCF Yield | -1.42% | US—/3,112 Sec—/206 |
| Profitability | ||
| ROE | -30.62% | US#2,622/3,112 Sec#162/206 |
| ROA | -15.37% | US#2,723/3,112 Sec#167/206 |
| Op. Margin | -7.72% | US#2,610/3,112 Sec#155/206 |
| Revenue Growth | 17.38% | US#847/3,112 Sec#54/206 |
| Financial Health | ||
| Debt Ratio | 99.23% | US#1,081/3,112 Sec#105/206 |
| Total Debt | $168M | US#2,250/3,112 Sec#124/206 |
| FCF | $-29M | US#2,402/3,112 Sec#168/206 |
| Cash | $94M | US#2,252/3,112 Sec#146/206 |
| Current Ratio | 3.09x | US#776/3,112 Sec#81/206 |
| Performance | ||
| 1Y Return | -33.21% | US#2,852/3,112 Sec#186/206 |
| 1M Return | 0.52% | US#1,569/3,112 Sec#104/206 |
| From 52W High | -60.29% | US#2,938/3,112 Sec#195/206 |
| 1Y MDD | -79.40% | US#3,042/3,112 Sec#199/206 |
| Trading | ||
| Volume | 1,355,951 shares | US#1,209/3,112 Sec#76/206 |
| Trading Value | $91M | US#981/3,112 Sec#78/206 |
| Per Share | ||
| EPS | $-0.78 | US—/3,112 Sec—/206 |
| BPS | $11.46 | US#1,690/3,112 Sec#97/206 |